首页> 外文期刊>Proteome science >The plasma proteomic signature as a strategic tool for early diagnosis of acute coronary syndrome
【24h】

The plasma proteomic signature as a strategic tool for early diagnosis of acute coronary syndrome

机译:血浆蛋白质组学特征作为急性冠状动脉综合征早期诊断的战略工具

获取原文
获取外文期刊封面目录资料

摘要

Background Acute coronary syndrome is the major cause of death in developed countries. Despite its high prevalence, there is still a strong need for new biomarkers which permit faster and more accurate diagnostics and new therapeutic drugs. The basis for this challenge lay in improving our understanding of the whole atherosclerotic process from atherogenesis to atherothrombosis. In this study, we conducted two different proteomic analyses of peripheral blood plasma from non-ST elevation acute coronary syndrome and ST elevation acute coronary syndrome patients vs healthy controls. Results Two-dimensional Fluorescence Difference in Gel Electrophoresis and mass spectrometry permitted the identification of 31 proteins with statistical differences (p?
机译:背景技术急性冠状动脉综合征是发达国家的主要死亡原因。尽管其流行率很高,但仍强烈需要能够更快,更准确的诊断方法和新治疗药物的新生物标记。这一挑战的基础在于增进我们对从动脉粥样硬化到动脉粥样硬化的整个动脉粥样硬化过程的理解。在这项研究中,我们对非ST段抬高的急性冠状动脉综合征和ST段抬高的急性冠状动脉综合征患者与健康对照者的外周血浆进行了两种不同的蛋白质组学分析。结果凝胶电泳和质谱法的二维荧光差异允许鉴定实验组之间31种具有统计学差异(p≤0.05)的蛋白质。此外,通过Western印迹和“选择反应监测”进行的验证使我们能够确定NSTEACS和STEACS患者血浆蛋白组学特征的不同特征。结论我们以缺氧的严重程度为基础来解释两组之间的差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号